Quest Diagnostics (DGX) Other Non-Current Assets (2009 - 2026)
Quest Diagnostics (DGX) posted Other Non-Current Assets of $277.0 million for Q2 2026, up 8.2% sequentially from $256.0 million in Q1 2026, and up 2.21% YoY from $271.0 million in Q2 2025.
Quest Diagnostics (DGX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Other Non-Current Assets for 18 years, with the latest figure at $277.0 million in Q2 2026.
- Quarterly Other Non-Current Assets rose 2.21% year-over-year to $277.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $277.0 million (up 2.21% YoY) and the FY2025 annual result came in at $270.0 million, up 5.88% from the prior year.
- Other Non-Current Assets rose to $277.0 million in Q2 2026 per DGX's latest filing, from $256.0 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $296.0 million in Q3 2025 and troughed at $132.0 million in Q3 2022.
- A 5-year average of $209.6 million and a median of $207.0 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets declined 22.16% in 2022, then soared 82.55% in 2024.
- Over 5 years, Other Non-Current Assets stood at $144.0 million in 2022, then jumped by 37.5% to $198.0 million in 2023, then climbed by 28.79% to $255.0 million in 2024, then advanced by 5.88% to $270.0 million in 2025, then advanced by 2.59% to $277.0 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $277.0 million, $256.0 million, and $270.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 49.99 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 567.73 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 769.30 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 277.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 277.00 Mn |
| Mar 31, 2026 | 256.00 Mn |
| Dec 31, 2025 | 270.00 Mn |
| Sep 30, 2025 | 296.00 Mn |
| Jun 30, 2025 | 271.00 Mn |
| Mar 31, 2025 | 260.00 Mn |
| Dec 31, 2024 | 255.00 Mn |
| Sep 30, 2024 | 272.00 Mn |
| Jun 30, 2024 | 216.00 Mn |
| Mar 31, 2024 | 182.00 Mn |
| Dec 31, 2023 | 198.00 Mn |
| Sep 30, 2023 | 149.00 Mn |
| Jun 30, 2023 | 152.00 Mn |
| Mar 31, 2023 | 150.00 Mn |
| Dec 31, 2022 | 144.00 Mn |
| Sep 30, 2022 | 132.00 Mn |
| Jun 30, 2022 | 137.00 Mn |
| Mar 31, 2022 | 155.00 Mn |
| Dec 31, 2021 | 163.00 Mn |
| Sep 30, 2021 | 155.00 Mn |